Clinical Study

Predictors of Cognitive Decline in the Early Stages of Parkinson's Disease: A Brief Cognitive Assessment Longitudinal Study

Table 1

Comparison between patients who remained in observation and those lost for follow-up.

Remained in observation ( )Lost for follow-up ( )

Gender (m)2840.370
Tremor subtype3470.977
Hallucinations ( )411.000
FAB < cut-off ( )1790.014*
MMSE < cut-off ( )420.638
Age 71.9 ± 7.5375.4 ± 4.550.099
Age of onset 69.1 ± 7.7672.7 ± 4.750.098
Duration2.8 ± 1.402.7 ± 1.270.891
Education 4.4 ± 4.224.1 ± 3.460.858
HY stage 1.8 ± 0.591.8 ± 0.540.845
DED390.0 ± 355.80487.5 ± 695.490.453
UPDRS total 18.6 ± 11.0515.5 ± 13.920.374
Dysarthria 0.6 ± 0.750.6 ± 0.750.987
Tremor 4.1 ± 3.714.1 ± 4.370.946
Rigidity 2.3 ± 3.071.7 ± 1.200.551
Bradykinesia7.4 ± 6.195.8 ± 6.730.377
Gait/posture1.4 ± 1.141.6 ± 1.280.609

Values are mean ± standard deviation, except for categorical variables.